Cooperative Research Partnerships into Therapeutics and Diagnostics for Biodefense Toxins (U01)

The summary for the Cooperative Research Partnerships into Therapeutics and Diagnostics for Biodefense Toxins (U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Cooperative Research Partnerships into Therapeutics and Diagnostics for Biodefense Toxins (U01): To support cooperative translational research into developing therapeutics and diagnostics for certain biodefense toxins: Shiga toxins, ricin toxin, the Staphylococcus enterotoxin B (SEB), Clostridium perfringens epsilon toxin, and the botulinum neurotoxins
Federal Grant Title: Cooperative Research Partnerships into Therapeutics and Diagnostics for Biodefense Toxins (U01)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-AI-06-035
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.85593.856
CFDA Descriptions: Allergy, Immunology and Transplantation Research 93.856 Microbiology and Infectious Diseases Research
Current Application Deadline: No deadline provided
Original Application Deadline: Nov 28, 2006
Posted Date: Jun 21, 2006
Creation Date: Jun 21, 2006
Archive Date: Dec 28, 2006
Total Program Funding: $10,000,000
Maximum Federal Grant Award: $500,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Others (see text field entitled "Additional Information on Eligibility" for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Public housing authorities/Indian housing authorities Special district governments Independent school districts For profit organizations other than small businesses Private institutions of higher education Public and State controlled institutions of higher education County governments Native American tribal governments (Federally recognized) State governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments)
Additional Information on Eligibility
Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply. Institutions must be in compliance with U.S. laws and regulations and DHHS and NIH policies in effect at the time of grant award and during the period of performance of the research. Collaborators at foreign institutions are allowed and encouraged, particularly when a diagnostic or therapeutic is targeting a disease that has a low incidence/prevalence in the USA and a high incidence/prevalence at a foreign settings where future product development activities may be planned.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster